×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Inhibrx Biosciences Inc.. (INBX) NASDAQ

$14.57 0.38 (2.68%)

Market Cap: $207.49M

As of 06/18/24 04:00 PM EDT. Market closed.

(INBX)

Inhibrx Biosciences Inc.. (INBX)
NASDAQ

$14.57
0.38 (2.68%)

Market Cap: $207.49M

As of 06/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

Inhibrx Inc. is a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates using proprietary modular protein engineering platforms. With a pipeline of therapeutic candidates targeting challenging, validated areas such as alpha-1 antitrypsin deficiency, oncology, and respiratory diseases, the company aims to create solutions to address high unmet medical ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
11025 N. Torrey Pines Road, Suite 200, La Jolla, California, La Jolla, 92037.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Mark Paul Lappe
Address
11025 N. Torrey Pines Road, Suite 200, La Jolla, California, La Jolla, 92037.
PRICE CHART FOR INHIBRX BIOSCIENCES INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.17
Previous Close
$14.19
Days Range
$13.85 - $14.68
52 week range
$13.85 - $18.95
Volume
109,598
Avg. Volume (30 days)
390,296
Market Cap
$207.49M
Dividend Yield
-
P/E
-
Shares Outstanding
14,241,175
Open
$14.17
Previous Close
$14.19
Days Range
$13.85 - $14.68
52 week range
$13.85 - $18.95
Volume
109,598
Avg. Volume (30 days)
390,296
Market Cap
$207.49M
Dividend Yield
-
P/E
-
Shares Outstanding
14,241,175
FINANCIAL STATEMENTS FOR INHIBRX BIOSCIENCES INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INHIBRX BIOSCIENCES INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kayyem Jon FaizDirectorJun 05, 2024 Buy$17.3257,549997,0241,150,410Jun 07, 2024, 06:05 PM
Kayyem Jon FaizDirectorMay 31, 2024 Buy$16.1470,1931,132,915876,268Jun 04, 2024, 05:27 PM
Kayyem Jon FaizDirectorJun 04, 2024 Buy$17.6589,0631,572,2401,092,861Jun 04, 2024, 05:27 PM
Kayyem Jon FaizDirectorJun 03, 2024 Buy$17.43127,5302,222,4251,003,798Jun 04, 2024, 05:27 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kayyem Jon FaizDirector06/05/2024997,024
Kayyem Jon FaizDirector05/31/20241,132,915
Kayyem Jon FaizDirector06/04/20241,572,240
Kayyem Jon FaizDirector06/03/20242,222,425
FUNDS WITH A POSITION IN INHIBRX BIOSCIENCES INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIKING GLOBAL INVESTORS LP00.00000%-100.00%Growth At A Reasonable Price
RA CAPITAL MANAGEMENT, L.P.2,629,8371.18%-44.33%Other
BLACKROCK INC.2,751,7050.00224%1.33%Other
CAPITAL RESEARCH GLOBAL INVESTORS712,3600.00666%ExitedGrowth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC704,8250.00228%2.54%Other
TIG ADVISORS, LLC333,9881.13%NewEvent Driven
WESTCHESTER CAPITAL MANAGEMENT, LLC257,3680.33%NewEvent Driven
PLATINUM INVESTMENT MANAGEMENT LTD145,9660.21%-12.99%Growth At A Reasonable Price, Value
CANDRIAM S.C.A.135,0690.04%ExitedOther
AQR ARBITRAGE LLC97,7740.12%NewEvent Driven
ALPINE GLOBAL MANAGEMENT, LLC35,0000.31%NewEvent Driven
ALPS ADVISORS INC33,4310.00827%0.98%Other
TUDOR INVESTMENT CORP ET AL18,3790.00562%ExitedEvent Driven, Other
ROYCE & ASSOCIATES LP12,9950.00456%ExitedValue
VIKING GLOBAL INVESTORS LP1,787,705nan%NewGrowth At A Reasonable Price
CHANGE IN SHARES OUTSTANDING FOR INHIBRX BIOSCIENCES INC.
STOCK BUYBACKS FOR INHIBRX BIOSCIENCES INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.82%
1Q
03/31/2024
09/30/2023
15.70%
2Q
03/31/2024
06/30/2023
25.00%
3Q
03/31/2024
03/31/2023
25.20%
4Q
03/31/2024
12/31/2022
25.98%
5Q
03/31/2024
09/30/2022
39.63%
6Q
03/31/2024
06/30/2022
39.74%
7Q
03/31/2024
03/31/2022
39.82%
8Q
03/31/2024
12/31/2021
41.38%
9Q
03/31/2024
09/30/2021
43.97%
10Q
03/31/2024
06/30/2021
44.23%
11Q
03/31/2024
03/31/2021
44.57%
12Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.82%
1Q
09/30/2023
15.70%
2Q
06/30/2023
25.00%
3Q
03/31/2023
25.20%
4Q
12/31/2022
25.98%
5Q
09/30/2022
39.63%
6Q
06/30/2022
39.74%
7Q
03/31/2022
39.82%
8Q
12/31/2021
41.38%
9Q
09/30/2021
43.97%
10Q
06/30/2021
44.23%
11Q
03/31/2021
44.57%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INHIBRX BIOSCIENCES INC.
LOADING...